Richard Bernstein Advisors’s Biogen BIIB Stock Holding History

Richard Bernstein Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,379	Closed	-$689K	–	215
2022 Q2	$689K	Hold	3,379	–	–	0.02%	213
2022 Q1	$712K	Hold	3,379	–	–	0.01%	244
2021 Q4	$811K	Sell	3,379 -2,215	-40%	-$570K	0.02%	250
2021 Q3	$1.58M	Buy	5,594 +430	+8%	+$141K	0.03%	228
2021 Q2	$1.79M	Hold	5,164	–	–	0.04%	209
2021 Q1	$1.44M	Hold	5,164	–	–	0.03%	228
2020 Q4	$1.26M	Sell	5,164 -2,561	-33%	-$661K	0.03%	225
2020 Q3	$2.19M	Hold	7,725	–	–	0.06%	154
2020 Q2	$2.07M	Hold	7,725	–	–	0.06%	160
2020 Q1	$2.44M	Sell	7,725 -3,389	-30%	-$1.03M	0.09%	127
2019 Q4	$3.3M	Hold	11,114	–	–	0.11%	144
2019 Q3	$2.59M	Hold	11,114	–	–	0.08%	168
2019 Q2	$2.6M	Hold	11,114	–	–	0.09%	166
2019 Q1	$2.63M	Hold	11,114	–	–	0.09%	190
2018 Q4	$3.34M	Hold	11,114	–	–	0.12%	165
2018 Q3	$3.93M	Buy	+11,114	New	+$3.83M	0.11%	199
2016 Q1	–	Sell	-13,496	Closed	-$4.13M	–	239
2015 Q4	$4.13M	Hold	13,496	–	–	0.53%	69
2015 Q3	$3.94M	Hold	13,496	–	–	0.54%	67
2015 Q2	$5.45M	Hold	13,496	–	–	0.66%	49
2015 Q1	$5.7M	Hold	13,496	–	–	0.75%	46
2014 Q4	$4.58M	Hold	13,496	–	–	0.47%	84
2014 Q3	$4.46M	Hold	13,496	–	–	0.47%	84
2014 Q2	$4.25M	Hold	13,496	–	–	0.5%	82
2014 Q1	$4.13M	Buy	13,496 +5,941	+79%	+$1.89M	0.59%	65
2013 Q4	$2.11M	Hold	7,555	–	–	0.43%	77
2013 Q3	$1.82M	Hold	7,555	–	–	0.54%	44
2013 Q2	$1.63M	Buy	+7,555	New	+$1.61M	0.54%	45

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Richard Bernstein Advisors's BIIB Position: Q3 2022 in Review

Richard Bernstein Advisors sold out of Biogen (BIIB) in Q3 2022, closing a stake of 3,379 shares — an estimated $689K sold.

Richard Bernstein Advisors first reported a position in BIIB in Q2 2013 and held it in 27 quarters. The position peaked at $5.7M in Q1 2015. 985 funds tracked by Wall St. Rank hold BIIB as of Q3 2022.

Richard Bernstein Advisors reported no remaining Biogen position as of Q3 2022 after selling out during the quarter.
Richard Bernstein Advisors sold 3,379 Biogen shares in Q3 2022, an estimated $689K.
Richard Bernstein Advisors first reported a position in Biogen in Q2 2013 and held it in 27 quarters.
Richard Bernstein Advisors's Biogen position peaked at $5.7M in Q1 2015.
985 funds tracked by Wall St. Rank held Biogen as of Q3 2022.

Based on Richard Bernstein Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.